Markwardt F, Stürzebecher J, Glusa E
Institute of Pharmacology and Toxicology, Medical Academy Erfurt, GDR.
Biomed Biochim Acta. 1990;49(5):399-404.
Three recombinant variants of hirudin with the most evident difference in amino acid position 47 (Lys-47, Arg-47, Asn-47) were studied for their selectivity and affinity for the target enzyme thrombin in comparison to native hirudin. Native hirudin and the recombinant hirudins inhibit selectively the clotting enzyme thrombin. The affinity of native hirudin does not differ significantly from that of recombinant hirudin Lys-47 whereas a distinctly lower affinity for thrombin is found for recombinant hirudin Arg-47 and recombinant hirudin Asn-47. All hirudins investigated have the same potency to inhibit thrombin-induced coagulation. Changes in the affinity of hirudins for thrombin become evident from the inhibition of thrombin-induced platelet aggregation only.
研究了三种在氨基酸位置47(赖氨酸-47、精氨酸-47、天冬酰胺-47)上差异最为明显的重组水蛭素变体,与天然水蛭素相比,考察了它们对靶酶凝血酶的选择性和亲和力。天然水蛭素和重组水蛭素可选择性抑制凝血酶。天然水蛭素与重组水蛭素赖氨酸-47对凝血酶的亲和力无显著差异,而重组水蛭素精氨酸-47和重组水蛭素天冬酰胺-47对凝血酶的亲和力明显较低。所有研究的水蛭素抑制凝血酶诱导的凝血的效力相同。水蛭素对凝血酶亲和力的变化仅从其对凝血酶诱导的血小板聚集的抑制作用中变得明显。